3-Fluoro-4-methoxybenzyl chloride, 97.0%, 5g

(2-Acetoxyethoxy)methyl Acetate>96.0%(GC)1g

Isoquinoline-4-carbonitrile, 95.0%, 1g

1-Bromo-3-methylnaphthalene, 95.0%, 1g

Methyl 4-(4-bromophenyl)-2,4-dioxobutanoate, 95.0%, 5g

1,2,3,3-Tetramethyl-3H-indol-1-ium iodide, 95.0%, 25g

4-(2-METHYLPHENOXY)BENZENESULFONYL CHLORIDE, 95.0%, 2.5g

4-(Trifluoromethyl)thiobenzamide, 97.0%, 100g

2-CHLORO-N-(PYRIDIN-3-YLMETHYL)ACETAMIDE HYDROCHLORIDE, 95%, 1g

Plan PLPHi S40x/0.65 objectif corrigé à l'infini IOS à contraste de phase

2-(2-Thienylmethylene)malononitrile, 95.0%, 250mg

2-Oxa-6-azaspiro[3.5]nonane, 97.0%, 100mg

3'-Hydroxyacetophenone>98.0%(GC)(T)500g